The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects Merck (NYSE: MRK), known as MSD outside of the United States and Canada, ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the start of construction for a $3 billion, 400,000-square-foot pharmaceutical ...

Biotech company, Armata Pharmaceuticals, is focused on the development of precisely targeted bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial ...

Astromech represents the strategic convergence of synthetic biology expertise with artificial intelligence development capabilities through the partnership of Ben Lamm and George Church. The venture ...

Astromech, a stealth-mode artificial intelligence startup, has successfully raised $30 million according to SEC filings. The company was co-founded by serial entrepreneur Ben Lamm and Harvard ...

For more than a decade, Boston has been the undisputed capital of the world’s life sciences industry. No other city really comes close. There is more lab space in Boston and Cambridge than anywhere in ...